AI Recruiter Conversation Demo - See How AI Engages Candidates on LinkedIn

1. To help you truly understand how our recruiter system works, we have selected real conversations from users using our AI recruiter on LinkedIn.
2. These examples show how our AI recruiter handles different scenarios.
3. All data has been strictly anonymized to protect personal information.

AI Recruiter Capabilities

What our AI Recruiter does in every conversation

7×24 Instant Reply

No timezone limits, responds within seconds anytime

Multi-language

Auto-detects language, supports 50+ languages

Intent Screening

Intelligently assesses candidate interest & willingness

Answer Questions

Answers role, salary, benefits inquiries automatically

Auto Follow-up

Proactive multi-round follow-up, zero manual effort

Schedule Interviews

Coordinates time slots & sends interview invitations

Get Contact Info

Naturally collects phone, email during conversation

Mic**ris

Company:ARC**ersPosition:MBA InternLocation:Chicago, Illinois,United States

Conversation Record

Hi M***l, I’m J***e, an HR recruiter at StrategyBrain. I was impressed by your leadership in A***n’s $175M Series C financing, your investor relations expertise at A***s, and your track record in corporate development and external communications. We’re working with B***s to find a Director of Corporate Development & Investor Relations,someone who can drive fundraising, M&A, pricing and market-access strategies, and stakeholder engagement. Would you be interested in a brief conversation to explore this opportunity? Looking forward to your thoughts. J***e

Hi J***e, thanks for reaching out,this Director role at B***s sounds intriguing. Could you share a bit more on the key priorities and team structure? I’d be happy to schedule a quick call.

Hi M***l, Great to hear you’re intrigued. At B***a, the Director of Corporate Development & Investor Relations will focus on: 1. Leading our next Series B/C fundraising rounds , you’ll own investor decks, due diligence coordination and communications with VCs and strategic partners. 2. Driving corporate development , identifying, evaluating and executing on partnerships, licensing deals and M&A opportunities to expand our oncology and immunology pipeline. 3. Shaping pricing, market access and health-economics strategies to ensure commercial readiness for lead assets. 4. Overseeing external communications , crafting press releases, social media content and investor presentations to raise B***a’s profile. 5. Building relationships with investors, patient-advocacy groups, KOLs and industry analysts to support our growth goals. You’d report into the VP of Finance & Corporate Development and lead a small, high-performing team (an associate and an analyst), working closely with R&D, commercial, medical affairs and corporate communications. Would you be open to a 20-minute call to dive deeper? I’m available tomorrow between 2:00,4:00 PM CT or Thursday morning 9:00,11:00 AM CT. Let me know what works best, and I’ll send a calendar invite. Looking forward to connecting, J***e

Thanks, J***e,this role sounds right up my alley given my Series C and market-access background. Before locking in a time, could you share a bit more on B***a’s current runway and lead asset clinical stage?

Hi M***l, Great question. B***a is venture-backed by leading life-science investors and has a healthy cash runway to support its operations and pipeline through the next 18,24 months, covering the key milestones for its lead program. That lead asset,an immuno-oncology candidate,has entered early clinical development (Phase I) with initial safety and biomarker readouts expected later this year. I can share more specific runway figures and a detailed clinical timeline on a quick call. Would you be open to tomorrow between 2:00,4:00 PM CT or Thursday morning 9:00,11:00 AM CT? Let me know what works best, and I’ll send over an invite. Looking forward to diving in, J***e

Thanks, J***e. Before we lock in a call, could you send over more detailed runway metrics and milestone timelines? I’ll review and then firm up a time.

Hi M***l, Happy to share a more detailed view: • Cash runway: provides funding through Q4 2025 (roughly 18,24 months) • Key clinical milestones for our lead immuno-oncology asset: , Q3 2024: complete Phase I dose-escalation cohorts , Q4 2024: report initial safety and biomarker readouts , Q1 2025: initiate Phase Ib expansion cohorts • Corporate milestones and fundraising timeline: , H1 2025: finalize data package and investor materials , H2 2025: target Series B/C financing round Let me know if you’d like any additional detail, and we can then lock in a time to dive deeper. Looking forward to your thoughts! Best, J***e

Thanks for the extra color, J***e. From my Series C experience, timelines often slip,any built-in buffer if Phase I dose-escalation runs past Q3? Also curious how big the current corp dev & IR team is and what bandwidth they have.

Hi M***l, Great questions. We do build in buffer around our Phase I dose-escalation milestone. While Q3 is our target, we’ve factored in a 6,8 week contingency window,so if cohorts run into early Q4, it won’t derail our overall fundraising timeline. We also have interim data checkpoints and internal alignment meetings to adjust investor materials or push our Series B/C cadence into H1 2025 if needed. As for the Corporate Development & IR team, it’s currently you plus two direct reports: - A Corporate Development Associate who handles deal screening, financial models and partner diligence - An IR Analyst who manages investor communications, reporting and deck production They’ve successfully supported our pre-clinical and early clinical fundraising to date, and both work closely with Finance Ops and Corporate Communications during peak periods. With your leadership, we’d look to optimize bandwidth further and potentially hire additional support as we ramp into the Series B/C phase. Hope this helps,let me know if you’d like to dive deeper or ready to lock in a time to chat. I’m free tomorrow 2:00,4:00 PM CT or Thursday 9:00,11:00 AM CT.

Thanks, J***e,this is great. Having led team expansions during A***n’s Series C, I’m curious how you’ll measure success in the first 6,12 months and whether there’s room to grow the team if deal flow outpaces expectations?

Hi M***l, Great question,totally makes sense given your A***n Series C experience. In the first 6,12 months, we’d measure success by: • Securing a lead investor commitment and advancing at least one term sheet into a binding agreement • Closing $50,75M in Series B/C funding on schedule (with built-in buffers) • Executing two to three strategic partnerships or licensing deals • Delivering clear, data-driven quarterly investor updates and building rapport with 10+ key investors/KOLs • Strengthening the team’s capabilities through streamlined processes and rapid onboarding of support roles On team growth, there’s definitely room to expand. As deal flow accelerates, we plan to add another Corporate Development Associate mid-year and consider a Senior IR Analyst or Business Development Associate to keep pace. You’d have the autonomy to shape hires and optimize bandwidth. This role is a unique chance to build B***a’s Corporate Development & IR function from the ground up, directly influence fundraising outcomes, and scale the team. Would you be open to a 20-minute call tomorrow between 2:00,4:00 PM CT or Thursday 9:00,11:00 AM CT to dive deeper? Let me know what works and I’ll send a calendar invite. Looking forward to your thoughts, J***e

More AI Conversation Examples

See how our AI Recruiter handles different candidate responses and scenarios

Currently viewing: No job change intention — AI follow-up & rapport building

Interested — Shared Contact Info

Candidate expressed strong interest, AI successfully collected phone number and email for recruiter follow-up

→

Not Now — Follow Up Later

Candidate is happy in current role but open to future contact, AI set a follow-up reminder

→

Asking Questions — AI Answered

Candidate asked about salary, remote policy, and team size — AI provided accurate, real-time answers

→

Declined — Not Interested

Candidate explicitly declined, AI responded professionally and preserved the relationship for future opportunities

→

How AI Recruiter Communicates with Candidates

Our AI follows a proven 5-step workflow: Smart Outreach → Needs Discovery → Intelligent Q&A → Collect Information → Schedule Interview.

1 Smart Outreach

AI analyzes the candidate's LinkedIn profile — job title, skills, industry, and career trajectory — then generates a highly personalized first message that highlights how the role matches their background and aspirations. The AI proactively reaches out at optimal times and adapts the message tone to each candidate's seniority level.

2 Needs Discovery

Through multi-round natural dialogue, AI uncovers the candidate's real career needs — including desired role type, salary expectations, work location preferences, growth priorities, and reasons for considering a change. This insight helps match them with the most relevant opportunities.

3 Intelligent Q&A

AI automatically answers candidates' questions about the role — including job responsibilities, salary range, benefits, team structure, work setup (remote/hybrid/on-site), and company culture. Responses are accurate, context-aware, and delivered instantly in the candidate's preferred language.

4 Collect Information

For interested candidates, AI naturally collects key information during the conversation — phone number, email address, salary expectations, earliest start date, and availability. All data is structured and synced to the recruiter dashboard in real time.

5 Schedule Interview

AI coordinates the candidate's and interviewer's availability, proposes suitable time slots, sends interview invitations with meeting details (link, agenda, interviewer info), and automatically sends reminders before the interview to minimize no-shows.